ORAL SUSTAINED RELEASE FORMULATION OF TEDISAMIL WITH GASTRIC RETENTION PROPERTIES

The present invention relates to a novel sustained release formulation with gastric retention properties comprising tedisamil or a pharmaceutically acceptable salt thereof and the use of this formulation in the prevention and treatment of atrial fibrillation, atrial flutter and cardiac ischemia. L&#...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	BAKKER, JOHAN A, DE WINTER, MARIUS L, FABIANO, SANTA
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to a novel sustained release formulation with gastric retention properties comprising tedisamil or a pharmaceutically acceptable salt thereof and the use of this formulation in the prevention and treatment of atrial fibrillation, atrial flutter and cardiac ischemia. L'invention concerne une nouvelle formulation à libération prolongée à propriétés de rétention gastrique comprenant du tédisamil ou un sel de celui-ci pharmaceutiquement acceptable, ainsi que son utilisation dans la prévention et le traitement de fibrillation auriculaire, du flutter auriculaire et de l'ischémie cardiaque.